LM
MXCT icon

Luminus Management’s MaxCyte MXCT Stock Holding History

Luminus Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$808K Buy
1,150,000
+913,505
+386% +$853K 0.49% 16
2025
Q4 		$367K Buy
236,495
+11,495
+5% +$18.4K 0.32% 18
2025
Q3 		$356K Buy
+225,000
New +$391K 0.32% 16

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Luminus Management's MXCT Position: Q1 2026 in Review

Luminus Management increased its MaxCyte (MXCT) stake by 386% in Q1 2026, buying an estimated $853K and bringing the position to 1,150,000 shares worth $808K. The position accounts for 0.49% of the portfolio, ranked #16.

Luminus Management first reported a position in MXCT in Q3 2025 and has held it in 3 quarters since. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Luminus Management held 1,150,000 shares of MaxCyte worth $808K as of Q1 2026.
  • Luminus Management bought 913,505 MaxCyte shares in Q1 2026, an estimated $853K.
  • MaxCyte made up 0.49% of Luminus Management's portfolio in Q1 2026, its #16 holding.
  • Luminus Management first reported a position in MaxCyte in Q3 2025 and has held it in 3 quarters since.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Luminus Management's 13F filing for Q1 2026, filed 15 May 2026.